Skip to main content
AORN Global Surgical Conference & Expo 2026 Main banner
Rate ePoster

Evidence-Based Practice

223 - Chemotherapy administration in the perioperative setting: an EBP project

Location: Hall E
Disclosure(s):
Laila S. Bailey, DNP, RN, CNS, CNOR, ACNS-BC: No financial relationships to disclose
Samantha Herbert, BSN, RN, CNOR: No relevant disclosure to display
Virginia Hansen, BSN, RN, CNOR: No financial relationships to disclose
Kerry C. Kaveney, BSN, RN, CNOR: No financial relationships to disclose
Julian Johnson Hamlet, RN, BSN, CNOR: No financial relationships to disclose
Susan Wooddell, BSN RN CNOR: No financial relationships to disclose


Description: Surgical procedures and new products to care for surgical patients are ever evolving. Keeping up with the innovations can be a challenge for perioperative nurses. Administration of chemotherapy in the perioperative setting is also an evolving process. Procedures such as HIPEC (hyperthermic intraperitoneal chemotherapy) surgery and interstitial administration of chemotherapy can potentially expose staff members to chemotherapy. Chemotherapeutic medication coated implants are new disposables that can deliver this high risk medication. Staff members that may not be familiar with these medications can be at risk of incidental exposure.
The Evidence Based Practice Committee of a large Level 1 Trauma Center identified that there was no policy in place to adeqately assist perioperative nurses in the care of patients receiving chemotherapy in the perioperative setting. We reviewed literature, met with experts i=on chemotherapy administration, and gatheterd data. The committee used this data to develop a perioperative specific chemotherapy administration policy. This poster will reflect the work done by the committee.